Ireland
--:--IST
Latest
Clinical Trials in Portugal / NCT07638358
Recruiting Phase EARLY_PHASE1

Assessment of the Impact of Neobone® (Biphasic Calcium Phosphate) on Bone Volume in Alveolar Ridge Preservation After Tooth Extraction

NCT07638358 · tracked via the Priya Life Science Portugal tracker
Phase
Phase EARLY_PHASE1
Started
2025-12-01
Last updated
2026-06-11

Condition(s) studied

Tooth Extraction Site HealingAlveolar Ridge Preservation

Investigational drug(s) / intervention(s)

Neobone® (Biphasic Calcium Phosphate)

Neobone® (Biphasic Calcium Phosphate): After tooth extraction the socket will be grafted with Neobone® (Biphasic Calcium Phosphate)

Study summary

The goal of this randomized clinical trial is to assess whether BCP (Biphasic Calcium Phosphate) improves alveolar ridge preservation (ARP) in patients who need tooth extraction. The main question it aims to answer is whether using BCP for alveolar ridge preservation has a positive effect on bone volume compared with natural healing.

The main questions it aims to answer are:

Does BCP improve ridge preservation compared with natural healing?

Researchers will compare BCP grafted sockets to natural healing sockets to see if BCP better preserves ridge volume.

Participants will:

Have a tooth indicated for extraction.

Be assigned to either BCP or natural healing.

Undergo CBCT (Cone Beam Computed Tomography) and intra-oral scanning after extraction and after six months of healing to measure horizontal and vertical resorption and bone density.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * 18 years or older * Acceptance of informed consent * Type 1 or 2 extraction sockets (Elian et al. 2007) Exclusion Criteria: * Presence of active infection or severe inflammation in the intervention zone * Relevant medical history that contraindicates implant surgery * Patients with poor oral hygiene (full-mouth plaque score and full-mouth bleeding score \>15%) and lack of motivation * Uncontrolled diabetes (reported levels of glycated haemoglobin exceeding 7%) * Uncontrolled and /or untreated periodontal disease * Heavy smokers (more than 10 cigarettes per day) * Immunosuppression

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Clinica Dentária Egas Moniz Caparica Monte Da Caparica Recruiting

More Egas Moniz - Cooperativa de Ensino Superior, CRL trials in Portugal

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07638358 on ClinicalTrials.gov ↗ ← All trials in Portugal